ADC Therapeutics S.A.
ADCT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,966 | -$56,646 | -$38,602 | -$30,727 |
| Dep. & Amort. | $122 | $1,490 | $801 | $236 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,000 | $2,062 | $2,421 | $2,779 |
| Change in WC | $392 | $21,566 | -$29,515 | $6,348 |
| Other Non-Cash | $8,822 | $7,441 | $8,561 | -$488 |
| Operating Cash Flow | -$29,630 | -$24,087 | -$56,334 | -$21,852 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$264 | -$90 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$264 | -$90 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$479 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$250 | $0 | -$1,163 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $281 | $94,033 | $271 | $43 |
| Financing Cash Flow | -$198 | $93,783 | $271 | -$1,120 |
| Forex Effect | $6 | $163 | $161 | -$343 |
| Net Chg. in Cash | -$29,822 | $69,859 | -$56,166 | -$23,405 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $264,560 | $194,701 | $250,867 | $274,272 |
| End Cash | $234,738 | $264,560 | $194,701 | $250,867 |
| Free Cash Flow | -$29,630 | -$24,087 | -$56,598 | -$21,942 |